Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome - PubMed (original) (raw)
. 2006 Jun;91(6):2447-50.
doi: 10.1210/jc.2005-2654. Epub 2006 Mar 7.
Hisashi Adachi, Akio Abe, Takako Yashiro, Mika Enomoto, Kumiko Furuki, Asuka Hino, Yuko Jinnouchi, Katsuhiko Takenaka, Takanori Matsui, Kazuo Nakamura, Tsutomu Imaizumi
Affiliations
- PMID: 16522692
- DOI: 10.1210/jc.2005-2654
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome
Sho-Ichi Yamagishi et al. J Clin Endocrinol Metab. 2006 Jun.
Abstract
Context: Pigment epithelium-derived factor (PEDF), a potent inhibitor of angiogenesis with neuronal differentiating activity, inhibits endothelial cell injury in vitro, thus suggesting the involvement of PEDF in atherosclerosis. Therefore, elucidating the relationship between serum levels of PEDF and coronary risk factors could provide a clue to understanding the pathophysiological role of PEDF in vivo.
Objective: We examined whether serum levels of PEDF were associated with risk factors for coronary artery disease.
Design: The study was designed as a cross-sectional study.
Setting: The study was set within the general community.
Patients or other participants: A total of 196 general Japanese residents (age 65.7 +/- 9.3 yr; 71 males and 125 females) without clinical evidence of coronary or peripheral arterial occlusive diseases were enrolled in this study.
Results: PEDF showed a normal distribution, ranging from 8-24 microg/ml, with a mean of 14.6 +/- 3.2 microg/ml. Multivariate analyses revealed that uric acid (P < 0.001), waist circumference (P = 0.009), insulin (P = 0.019), and triglycerides (P = 0.028) were significant independent determinants of serum PEDF levels. Age- and uric acid-adjusted PEDF levels were significantly higher (P = 0.048 for men and P = 0.007 for women) in proportion to the accumulation of the number of the components of the metabolic syndrome.
Conclusions: The present study reveals that serum levels of PEDF are strongly associated with the metabolic syndrome. Our results suggest that serum PEDF levels may be elevated as a counter-system in the metabolic syndrome.
Similar articles
- Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Inoue H. Nakamura K, et al. Diabetes Metab Res Rev. 2009 Jan;25(1):52-6. doi: 10.1002/dmrr.820. Diabetes Metab Res Rev. 2009. PMID: 18677713 - Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study.
Chen C, Tso AW, Law LS, Cheung BM, Ong KL, Wat NM, Janus ED, Xu A, Lam KS. Chen C, et al. J Clin Endocrinol Metab. 2010 Nov;95(11):5074-81. doi: 10.1210/jc.2010-0727. Epub 2010 Aug 4. J Clin Endocrinol Metab. 2010. PMID: 20685859 - C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome.
Choi KM, Hwang SY, Hong HC, Yang SJ, Choi HY, Yoo HJ, Lee KW, Nam MS, Park YS, Woo JT, Kim YS, Choi DS, Youn BS, Baik SH. Choi KM, et al. Diabetes. 2012 Nov;61(11):2932-6. doi: 10.2337/db12-0217. Epub 2012 Jul 26. Diabetes. 2012. PMID: 22837306 Free PMC article. Clinical Trial. - Pigment epithelium-derived factor (PEDF) and cardiometabolic disorders.
Yamagishi S, Matsui T. Yamagishi S, et al. Curr Pharm Des. 2014;20(14):2377-86. doi: 10.2174/13816128113199990473. Curr Pharm Des. 2014. PMID: 23844817 Review. - Pigment epithelium-derived factor: a not so sympathetic regulator of insulin resistance?
Bell C. Bell C. Exerc Sport Sci Rev. 2011 Oct;39(4):187-90. doi: 10.1097/JES.0b013e31822673f0. Exerc Sport Sci Rev. 2011. PMID: 21697716 Review.
Cited by
- Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.
Belinsky GS, Sreekumar B, Andrejecsk JW, Saltzman WM, Gong J, Herzog RI, Lin S, Horsley V, Carpenter TO, Chung C. Belinsky GS, et al. FASEB J. 2016 Aug;30(8):2837-48. doi: 10.1096/fj.201500027R. Epub 2016 Apr 28. FASEB J. 2016. PMID: 27127101 Free PMC article. - Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people.
Sunderland KL, Tryggestad JB, Wang JJ, Teague AM, Pratt LV, Zhang SX, Thompson DM, Short KR. Sunderland KL, et al. J Clin Endocrinol Metab. 2012 Nov;97(11):E2114-8. doi: 10.1210/jc.2012-1894. Epub 2012 Aug 28. J Clin Endocrinol Metab. 2012. PMID: 22930782 Free PMC article. - Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy.
Yoshida Y, Yamagishi S, Matsui T, Nakamura K, Imaizumi T, Yoshimura K, Yamakawa R. Yoshida Y, et al. Br J Ophthalmol. 2007 Sep;91(9):1133-4. doi: 10.1136/bjo.2007.115188. Epub 2007 Mar 27. Br J Ophthalmol. 2007. PMID: 17389742 Free PMC article. - Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy.
Matsuyama K, Ogata N, Matsuoka M, Shima C, Wada M, Jo N, Matsumura M. Matsuyama K, et al. Mol Vis. 2008 May 28;14:992-6. Mol Vis. 2008. PMID: 18523656 Free PMC article. - Pigment epithelium-derived factor inhibits caveolin-induced interleukin-8 gene expression and proliferation of human prostate cancer cells.
Matsui T, Ojima A, Higashimoto Y, Taira J, Fukami K, Yamagishi SI. Matsui T, et al. Oncol Lett. 2015 Oct;10(4):2644-2648. doi: 10.3892/ol.2015.3568. Epub 2015 Aug 4. Oncol Lett. 2015. PMID: 26622904 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous